247 related articles for article (PubMed ID: 33831141)
21. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
[TBL] [Abstract][Full Text] [Related]
22. A protective chimeric antibody to tick-borne encephalitis virus.
Baykov IK; Matveev AL; Stronin OV; Ryzhikov AB; Matveev LE; Kasakin MF; Richter VA; Tikunova NV
Vaccine; 2014 Jun; 32(29):3589-94. PubMed ID: 24837772
[TBL] [Abstract][Full Text] [Related]
23. Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies.
Gallichotte EN; Young EF; Baric TJ; Yount BL; Metz SW; Begley MC; de Silva AM; Baric RS
mBio; 2019 Sep; 10(5):. PubMed ID: 31530669
[TBL] [Abstract][Full Text] [Related]
24. Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein.
Kreil TR; Maier E; Fraiss S; Eibl MM
J Virol; 1998 Apr; 72(4):3076-81. PubMed ID: 9525632
[TBL] [Abstract][Full Text] [Related]
25. Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice.
Khoretonenko MV; Vorovitch MF; Zakharova LG; Pashvykina GV; Ovsyannikova NV; Stephenson JR; Timofeev AV; Altstein AD; Shneider AM
Immunol Lett; 2003 Dec; 90(2-3):161-3. PubMed ID: 14687719
[TBL] [Abstract][Full Text] [Related]
26. Antibody-dependent enhancement of tick-borne encephalitis virus infectivity.
Phillpotts RJ; Stephenson JR; Porterfield JS
J Gen Virol; 1985 Aug; 66 ( Pt 8)():1831-7. PubMed ID: 2991448
[TBL] [Abstract][Full Text] [Related]
27. Computational and Rational Design of Single-Chain Antibody against Tick-Borne Encephalitis Virus for Modifying Its Specificity.
Baykov IK; Desyukevich PY; Mikhaylova EE; Kurchenko OM; Tikunova NV
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452359
[TBL] [Abstract][Full Text] [Related]
28. A critical determinant of neurological disease associated with highly pathogenic tick-borne flavivirus in mice.
Yoshii K; Sunden Y; Yokozawa K; Igarashi M; Kariwa H; Holbrook MR; Takashima I
J Virol; 2014 May; 88(10):5406-20. PubMed ID: 24574402
[TBL] [Abstract][Full Text] [Related]
29. New Neutralizing Epitope Exposed on the Domain II of Tick-Borne Encephalitis Virus Envelope Glycoprotein E.
Matveev A; Khlusevich Y; Kozlova I; Matveev L; Emelyanova L; Tikunov A; Baykov I; Tikunova N
Viruses; 2023 May; 15(6):. PubMed ID: 37376556
[No Abstract] [Full Text] [Related]
30. Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin.
Chernokhaeva LL; Rogova YV; Vorovitch MF; Romanova LIu; Kozlovskaya LI; Maikova GB; Kholodilov IS; Karganova GG
Vaccine; 2016 Apr; 34(20):2354-61. PubMed ID: 27013433
[TBL] [Abstract][Full Text] [Related]
31. Antigenic relationships among viruses of the tick-borne encephalitis complex as studied by monoclonal antibodies.
Gresíková M; Sekeyová M
Acta Virol; 1984 Jan; 28(1):64-8. PubMed ID: 6201061
[TBL] [Abstract][Full Text] [Related]
32. Tick-borne encephalitis virus and louping-ill virus may co-circulate in Southern Norway.
Ytrehus B; Vainio K; Dudman SG; Gilray J; Willoughby K
Vector Borne Zoonotic Dis; 2013 Oct; 13(10):762-8. PubMed ID: 23808981
[TBL] [Abstract][Full Text] [Related]
33. Sequence of the genes encoding the structural proteins of the low-virulence tick-borne flaviviruses Langat TP21 and Yelantsev.
Mandl CW; Iacono-Connors L; Wallner G; Holzmann H; Kunz C; Heinz FX
Virology; 1991 Dec; 185(2):891-5. PubMed ID: 1720591
[TBL] [Abstract][Full Text] [Related]
34. Tick-borne encephalitis virus (TBEV) - findings on cross reactivity and longevity of TBEV antibodies in animal sera.
Klaus C; Ziegler U; Kalthoff D; Hoffmann B; Beer M
BMC Vet Res; 2014 Apr; 10():78. PubMed ID: 24690234
[TBL] [Abstract][Full Text] [Related]
35. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
[TBL] [Abstract][Full Text] [Related]
36. An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice.
Eyer L; Nougairède A; Uhlířová M; Driouich JS; Zouharová D; Valdés JJ; Haviernik J; Gould EA; De Clercq E; de Lamballerie X; Ruzek D
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142664
[TBL] [Abstract][Full Text] [Related]
37. Tick-borne encephalitis.
Gritsun TS; Lashkevich VA; Gould EA
Antiviral Res; 2003 Jan; 57(1-2):129-46. PubMed ID: 12615309
[TBL] [Abstract][Full Text] [Related]
38. Type I interferon protects mice from fatal neurotropic infection with Langat virus by systemic and local antiviral responses.
Weber E; Finsterbusch K; Lindquist R; Nair S; Lienenklaus S; Gekara NO; Janik D; Weiss S; Kalinke U; Överby AK; Kröger A
J Virol; 2014 Nov; 88(21):12202-12. PubMed ID: 25122777
[TBL] [Abstract][Full Text] [Related]
39. Needle-free jet injection of DNA and protein vaccine of the far-eastern subtype of tick-borne encephalitis virus induces protective immunity in mice.
Omori-Urabe Y; Yoshii K; Ikawa-Yoshida A; Kariwa H; Takashima I
Microbiol Immunol; 2011 Dec; 55(12):893-7. PubMed ID: 22004565
[TBL] [Abstract][Full Text] [Related]
40. Human CD4+ T Helper Cell Responses after Tick-Borne Encephalitis Vaccination and Infection.
Aberle JH; Schwaiger J; Aberle SW; Stiasny K; Scheinost O; Kundi M; Chmelik V; Heinz FX
PLoS One; 2015; 10(10):e0140545. PubMed ID: 26465323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
